Journal
/
Cancer Research
/
Assays for Validating Histone Acetyltransferase Inhibitors
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Assays for Validating Histone Acetyltransferase Inhibitors

Assays for Validating Histone Acetyltransferase Inhibitors

DOI:
10.3791/61289-v

•

09:11 min

•

August 06, 2020

•

,
1Department of Anatomy and Cell Biology, and UF Health Cancer Center,University of Florida College of Medicine

Chapters

  • 00:04Introduction
  • 00:39In Vitro HAT Assay
  • 01:37ChHAI Assay
  • 03:11Chromatin Immunoprecipitation (ChIP)
  • 05:48Results: Inhibitors of Histone Acetyltransferases
  • 08:19Conclusion

Summary

Automatic Translation

Automatic Translation

Inhibitors of histone acetyltransferases (HATs, also known as lysine acetyltransferases), such as CBP/p300, are potential therapeutics for treating cancer. However, rigorous methods for validating these inhibitors are needed. Three in vitro methods for validation include HAT assays with recombinant acetyltransferases, immunoblotting for histone acetylation in cell culture, and ChIP-qPCR.

Tags

Histone AcetyltransferaseHAT InhibitorEpigenetic RegulationEnzymatic ReactionHistone AcetylationSDS-PAGEImmunoblottingMCF-7 CellsMS275A-485Passive Lysis BufferChromatin Immunoprecipitation

Article

Embed

ADD TO PLAYLIST

Usage Statistics

Related Videos

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Read Article